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The positron annihilation lifetime spectroscopy was applied to the samples of the human uterine leiomyomas
and the normal myometrium tissues taken from the selected place of the uterus during a surgery. The method
indicated differences in values of the measured positron annihilation lifetime spectroscopy parameters (lifetimes
and intensities) between healthy and diseased tissue samples. The additional measurements were performed either
in darkness or in presence of visible light which influenced the free radicals present in both kind of tissues and, as
a result, made changes in free annihilation and o-Ps decay lifetime and intensity values.
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1. Introduction
Positron annihilation lifetime spectroscopy (PALS),
the method based on a behaviour of thermalized positron
in the medium, is commonly used in investigations of var-
ious kind of materials: from metals and semiconductors
to complex mesoporous substances [1, 2].
In the materials where positronium (Ps) is created, the
o-Ps lifetime correlation with the size of the void in which
the positronium is trapped [3–9] allows to determine the
void sizes from 0.2 to about 100 nm and follow many
processes undergoing in the medium. PALS techniques
were applied, however, in a very limited number of papers
concerning living biological systems [10–15]. As the o-
Ps lifetime reflects changes in the material structure, it
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should be connected to the morphology of the cells of the
living organisms [16].
A precise understanding of various chemical processes
in biological systems is of the greatest importance es-
pecially if this understanding contributes to improving
a human body diagnosis. The o-Ps and free annihila-
tion lifetime and intensity should be connected to the
physiology of these cells. These parameters could be
probably used as an indicator of the state of disorder
in these cells caused by changes in cells’ chemical pro-
cesses and structure deformations [16, 17]. A great deal
of physiological processes are related to chemical reac-
tions producing or removing free radicals. They influence
the processes of positronium formation and positron an-
nihilation and hence could affect the PALS results. The
significant difference between a normal and a tumorous
tissues is manifested, among others, by different concen-
trations of free radicals. In general, because tumorous
tissues are involved in many unspecific processes and thus
(1556)
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a greater amount of their genes are involved, so the elec-
tron concentration (and a density of other radicals) in
altered sample should be larger. They should influence
the intensity of free annihilation. The intensity values
of PALS components were successfully applied to follow
concentration of the free radicals and trapped electrons in
the organic materials [18–20]. It has already been shown
that illumination of a sample influences the shape of the
lifetime spectrum by changing the concentration of free
radicals [21–23]. Such results justify an expectation of
PALS applicability to free radicals investigations in bio-
logical systems.
One of the most known diagnostic techniques, positron
emission tomography (PET), is also based on positron
behavior in the living organism therefore in principle it
is possible to implement results of PALS measurements
to future PET diagnostic ability. The innovative con-
struction concept was recently proposed by the J-PET
collaboration [24–31]. One of the advantages of J-PET
is a possibility of multi-photon imaging [32, 33] which
enables the diagnosis based on positron and positronium
lifetime [16] as well as on the ratio of 3γ and 2γ annihi-
lation rates [17, 34, 35].
In this paper, the healthy and diseased human uterus
tissues are investigated using PALS in order to compare
modifications in lifetime and intensity values for samples
caused by visible light. The uterus was chosen as an ob-
ject of investigation as it is possible to obtain samples of
normal and altered tissues from the same organ of the
same patient so the observed changes in PALS param-
eters are due to the alteration only and are not related
to other factors which can differ from patient to patient.
Additionally, the presence of oxidative DNA damage and
DNA adducts in uterus was stated before [36–40].
2. Experimental
The tissues were provided from the patients qualified
for a surgical removal of the changed tissue. The samples
were taken directly from the organ, just after a removal
of the uterus by the surgeon in the operating room. The
tissue fragments were taken from the sites altered macro-
scopically (A) and those identified as a normal (N) tissue.
Each sample, with the total volume of about 1.5 cm3,
was placed in a cylindrical, steel PALS chamber, divided
in half by a Plexiglas partition element and closed with
a steal seal. The samples were delivered to the PALS
laboratory in transporting thermos, at the constant tem-
perature (23±1 ◦C) in less than 1 h. In our laboratory, a
22Na source (of the activity 0.7 MBq) was placed inside
the Plexiglas partition and inserted between two slices of
investigated sample. Each sample was measured for 1.5 h
using a standard fast-slow PALS spectrometer. Gamma
quanta from positron creation and positron/positronium
annihilation were collected by two BaF2 scintillation de-
tectors. The time range of time-to-amplitude converter
(TAC) was set on 100 ns, which allowed for a precise mea-
surement of lifetimes up to a few ns. The resolution curve
was approximated with the use of a single Gaussian, with
the FWHM of about 0.25 ns. The lifetime spectra were
analyzed with the use of LT 9.2 [41] program and three
components, ascribed to: p-Ps, unbound positrons and
o-Ps annihilation, were distinguished.
After the measurement in the darkness, the sample was
transferred to a quartz glass container and then the spec-
tra for the illuminated sample were collected (light from
a 20 W lamp placed at the distance of 40 cm, to min-
imize the sample heating). After PALS measurements,
the samples were thoroughly rinsed with formalin and
transported to the hospital for a histopathological exam-
ination. The histopathological photos clearly show the
morphological diversity of the tested samples [15].
Our study was made under the approval of the
Bioethics Committee of the Medical University of Lublin.
3. Results and discussion
From PALS measurement it was found that there exist
significant differences of results obtained from different
female patients as well as between normal (N) and altered
(A) tissues from the same patient [15]. Comparison of
results for the first points in regions II and III in Fig. 1
confirms this conclusion.
Fig. 1. The lifetime and intensity values for normal
(blue diamonds) and altered (red dots) uterine tissue.
Upper and lower parts show the mean lifetime and inten-
sity of three main annihilation components originating
from para-positronium (left), direct annihilation (mid-
dle) and ortho-positronium (right). The first points
for both patients were measured in darkness, the sec-
ond (and third — elongated exposition time) — light
illuminated. Three regions in the figure from left to
right: deionized water at room temperature (crosses),
patient I, patient II.
Preliminary measurements of free radicals examination
presented here were performed for two patients from the
same group of samples. In Fig. 1 results of measurements
for both patients in darkness and exposed to the light
are shown. From PALS parameter one can conclude that
an exposition of the samples to light makes a significant
impact on altered tissue only (Fig. 1, red points). The
greatest difference can be seen for free positrons (second
component). The lifetime τ2 is significantly shortened
for the illuminated altered tissue samples, while the ade-
quate intensity fraction increases. In the case of normal
tissue samples, no such effects are observed during illu-
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mination of samples — the differences in the PALS pa-
rameters in illuminated and non-illuminated samples are
small. In the tissues positron can interact with both the
dense matter and the biofluids. To estimate the influence
of processes related to water (in cells), lifetime and in-
tensity values of all components determined in deionized
water are also presented for comparison (crosses).
A higher density of electrons (radicals) in the altered
sample results in increasing probability of the free e+
annihilation and the probability of the positronium cre-
ation.
4. Conclusions
Light influences significantly results of the PALS mea-
surements obtained for cancerous samples while this ef-
fect for normal tissues is negligible or barely marked for
o-Ps lifetime value only. It should be noted that the
metabolism of dying cells may additionally affect the re-
sults of the measurements as well as the diversity in phys-
iological processes of patients. However, the presented re-
sults of these pilot studies are encouraging for applying
PALS and PET in early stages of pathogenic alteration
in the body.
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